HPV Vaccines
Product Description
Click here to view a sample of this brochure.
Quantity per order: 50 (Shrink wrapped bundle)
* 2008 National Health Information Award Winner *
HPV/cervical cancer vaccines have great potential as a public health tool. Legislators in at least 41 states and D.C. have introduced legislation to require, fund or educate the public about the HPV Vaccine and at least 17 states have enacted this legislation.
In clear language, ASHA's "HPV Vaccines" gives an overview of low-risk and high-risk types of HPV and answers specific questions about HPV vaccines, addressing issues of safety, efficacy, ACIP recommendations and cost. Drawing on the latest research developments, the brochure also answers questions about vaccination for males and women over 26, the use of vaccine as treatment, and the need for continued cervical cancer screening after vaccination.
If you serve patients for whom HPV vaccination would be recommended and appropriate, this brochure is a must. Help your patients become informed to make an important decision about this new vaccine.
Quantity per order: 50 (Shrink wrapped bundle)
* 2008 National Health Information Award Winner *
HPV/cervical cancer vaccines have great potential as a public health tool. Legislators in at least 41 states and D.C. have introduced legislation to require, fund or educate the public about the HPV Vaccine and at least 17 states have enacted this legislation.
In clear language, ASHA's "HPV Vaccines" gives an overview of low-risk and high-risk types of HPV and answers specific questions about HPV vaccines, addressing issues of safety, efficacy, ACIP recommendations and cost. Drawing on the latest research developments, the brochure also answers questions about vaccination for males and women over 26, the use of vaccine as treatment, and the need for continued cervical cancer screening after vaccination.
If you serve patients for whom HPV vaccination would be recommended and appropriate, this brochure is a must. Help your patients become informed to make an important decision about this new vaccine.
